Home > Insider Trading > Filing (0001181431-12-006820)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1183765	Threshold Pharmaceuticals Inc	THLD	Pharmaceutical Preparations (2834)	943409596

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1456654	Fhm Vi, L.l.c.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1456655	Fhm Vi, L.p.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1456656	Frazier Healthcare Vi, L.p.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-02-07	300,000	$3.02	4,579,081	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2012-02-07	300,000	$3.02	4,579,081	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2012-02-07	300,000	$3.02	4,579,081	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Direct

Footnotes

These shares were sold by Frazier Healthcare VI. L.P. ("FH VI"). FHM VI, L.L.C. ("FHM VI L.L.C.") is the general partner of FHM VI., L.P. ("FHM VI"), which is the general partner of FH VI. FHM VI L.L.C. may be deemed to have voting and dispositive power with respect to the securities held by FH VI. FHM VI L.L.C. disclaims beneficial ownership of the securities held by FH VI except to the extent of any pecuniary interest therein.
These shares were sold by FH VI. FHM VI is the general partner of FH VI and may be deemed to have voting and dispositive power with respect to the securities held by FH VI. FHM VI disclaims beneficial ownership of the securities held by FH VI except to the extent of any pecuniary interest therein.
These shares were sold by FH VI.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.10, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.